2025 HCPCS Code C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

TAGS: viable brexucabtagene positive preparation leukapheresis autologous therapeutic million
NoticeHCPCS C9073 terminated on March 31, 2021.
Short DescriptionBrexucabtagene autoleucel ca
HCPCS Action Code N - No maintenance for this code
HCPCS Coverage Code D - Special coverage instructions apply
HCPCS Code Added Date January 01, 2021
HCPCS Action Effective Date April 01, 2021
HCPCS Pricing Indicator Code 53 - Statute
HCPCS Type Of Service Code 9 - Other medical items or services
HCPCS Multiple Pricing Indicator Code A - Not applicable as HCPCS priced under one methodology
HCPCS Anesthesia Base Unit Quantity 0
HCPCS Coverage Issues Manual Reference Section Number

Check Similar HCPCS Codes